Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 26, 2023.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
The director of the Memory & Cognitive Disorders Clinic at Hoag Neuroscience Institute discussed the future of treating Parkinson disease psychosis, and potential ways to lower risk of poor long-term outcomes. [WATCH TIME: 3 minutes]
In episode 10 of this Peer Exchange series on "The Shifting Treatment Landscape of RRMS", expert neurologists discuss treatment options for a patient with comorbid autoimmune diseases, relapsing/remitting multiple sclerosis, and psoriasis.
In the latest edition of our in-depth Q&A series, the senior associate consultant in the Department of Neurology at Mayo Clinic provided insight on an early feasibility study on the clinical impact of microburst vagus nerve stimulation in patients with drug-resistant epilepsy.
For ALS Awareness Month — May 2023 —the team has culminated some of the biggest pieces of news to offer updates on new developments in literature in ALS to spread awareness on the prevention and treatment the neuromuscular disease.
The director of vascular neurology at NYU Langonediscuss stroke warning signs and prevention. He talked about the "BE-FAST” acronym and what each letter represents in terms of stroke symptoms to recognize. [WATCH TIME: 4 minutes]